Your browser doesn't support javascript.
Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study).
Takada, Kazuki; Takamori, Shinkichi; Miura, Naoko; Shikada, Yasunori; Shimokawa, Mototsugu.
  • Takada K; Department of Surgery, Saiseikai Fukuoka General Hospital, 1-3-46 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan.
  • Takamori S; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan. Electronic address: shinkichi.takamori@gmail.com.
  • Miura N; Department of Surgery, Saiseikai Fukuoka General Hospital, 1-3-46 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan.
  • Shikada Y; Department of Surgery, Saiseikai Fukuoka General Hospital, 1-3-46 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan.
  • Shimokawa M; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi, 755-8505, Japan.
Eur J Cancer ; 157: 529-530, 2021 11.
Article in English | MEDLINE | ID: covidwho-1401446

Full text: Available Collection: International databases Database: MEDLINE Main subject: Neuroendocrine Tumors / COVID-19 Type of study: Observational study / Randomized controlled trials Limits: Humans Language: English Journal: Eur J Cancer Year: 2021 Document Type: Article Affiliation country: J.ejca.2021.07.046

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Neuroendocrine Tumors / COVID-19 Type of study: Observational study / Randomized controlled trials Limits: Humans Language: English Journal: Eur J Cancer Year: 2021 Document Type: Article Affiliation country: J.ejca.2021.07.046